NEW DELHI, May 8, 2025 — Dharamshila Narayana Superspeciality Hospital announces a milestone achievement in thalassemia treatment, as young patient Gaurvik celebrates two years free from blood transfusions following a pioneering haploidentical bone marrow transplant (BMT).

Diagnosed with Beta Thalassemia Major at just six months of age, Gaurvik’s life began with regular hospital visits and constant blood transfusions. The only curative option for his condition was an allogenic bone marrow transplant, which typically requires a fully HLA-matched donor, often a challenging requirement with only a 25% chance of siblings being a complete match.

When testing revealed that Gaurvik’s sister Ananya was only a half match, his family turned to the specialized team at Dharamshila Narayana Superspeciality Hospital. Under the leadership of Dr. Suparno Chakrabarti and Dr. Sarita Rani Jaiswal, pioneers in haploidentical transplantation, a groundbreaking solution was implemented.

“Haploidentical BMT represents a significant advancement in thalassemia treatment,” said Dr. Suparno Chakrabarti, Head of Hematology and BMT at Dharamshila Narayana Superspeciality Hospital. “When we began this mission in 2014, we envisioned creating hope for every thalassemia patient, regardless of donor availability. Gaurvik’s success story validates our perseverance through countless challenges.”

Gaurvik underwent the transplant at age two on May 1, 2023, with his sister serving as the donor. Today, two years post-transplant, he enjoys a normal, healthy childhood without dependence on transfusions.

Dr. Sarita Jaiswal, who managed Gaurvik’s care from eight months of age, remarked, “Watching Gaurvik transform from a transfusion-dependent infant to a thriving, healthy child has been profoundly rewarding. His journey represents the culmination of medical innovation, specialized care protocols, and the extraordinary resilience of both patient and family. This case demonstrates that with advanced transplant techniques, we can now offer curative options to virtually every thalassemia patient, even without fully matched donors.”

Dharamshila Narayana Superspeciality Hospital continues its mission, which was initiated in 2014, to cure all children with Thalassemia Major who lack HLA-matched family donors.